Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 9, 2026

Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis
06:56

Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis

Published on: September 22, 2023

1.7K

Antineoplastons: when is enough enough?

William D Figg

    The Lancet. Oncology
    |June 13, 2018
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis
    06:56

    Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis

    Published on: September 22, 2023

    1.7K

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa.

    AIDS reviews·2020
    Same author

    Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (<i>Macaca mulatta</i>) Based on the Pharmacokinetics of Intrathecally Administered Inulin.

    Comparative medicine·2020
    Same author

    A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.

    Blood·2020
    Same author

    Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.

    BJU international·2020
    Same author

    Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma.

    Molecular cancer therapeutics·2020
    Same author

    Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition.

    ACS medicinal chemistry letters·2020
    Same journal

    New report sheds light on cancer disparities in the USA.

    The Lancet. Oncology·2026
    Same journal

    Review highlights gaps in South Africa's cancer care.

    The Lancet. Oncology·2026
    Same journal

    Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

    The Lancet. Oncology·2026
    Same journal

    Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026
    Same journal

    Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

    The Lancet. Oncology·2026
    Same journal

    European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

    The Lancet. Oncology·2026
    See all related articles